Skip to content
OpenCapital
Get started

Twist Bioscience Corporation TWST Q2 2026 earnings

Reported May 4, 2026 · Before market open

Revenue$110.7MBeat by $3.1M
EPS-$0.62Miss by $0.13
Revenue estimate$107.6M
EPS estimate-$0.49

Next report

Aug 3, 2026 (In 5 days)
Revenue estimate$114.5M
EPS estimate-$0.50

Financials

Q2 2026

Income statement

See full
Revenue$110.7M+19.3%
Gross profit$57.1M+24.1%
Operating income-$45.9M-10.4%
Net income-$44.0M-11.9%
EPS (diluted)-$0.71-7.6%

Balance sheet

See full
Cash & equivalents$124.9M-41.4%
Total debt$110.8M+16.3%
Total equity$455.1M+3.4%
Total assets$676.2M+13.5%

Cash flow

See full
Operating cash flow-$17.6M-35.2%
CapEx$7.9M+90.3%
Free cash flow-$25.4M-48.5%

Valuation & ratios

Valuation

as of 07/28/26
See full
Market cap$5.39B+146%
Enterprise value$5.37B+159%
P/S13.2×+7.1×

Profitability

See full
Gross margin52.1%+5.4pp
Operating margin-33.9%-9.9pp
Net margin-19.8%-7.7pp
FCF margin-23.2%+7.0pp

Returns & leverage

See full
Return on equity-18.2%-6.3pp
Debt / equity0.2×0.0×
Current ratio2.7×-1.8×

Segments

By geography

See full
Americas$64.3M+16.5%
EMEA$37.3M+21.9%
APAC$9.1M+30.1%

By product

See full
NGS applications$57.4M+12.3%
DNA synthesis and protein solutions$53.3M+27.9%

By segment

See full
Reportable Segment$110.7M+19.3%

Versus estimates

Revenue

Q2 2026$110.7MBeat by $3.1M
Q1 2026$103.7MBeat by $1.8MQ4 2025$99.0MBeat by $1.6MQ3 2025$96.1MMiss by $1.3MQ2 2025$92.8MMiss by $2.6MQ1 2025$88.7MBeat by $1.8M

Diluted EPS

Q2 2026-$0.62Miss by $0.13
Q1 2026-$0.50Miss by $0.02Q4 2025-$0.45Beat by $0.05Q3 2025-$0.47Beat by $0.07Q2 2025-$0.66Miss by $0.10Q1 2025-$0.53Beat by $0.09

Ask the moment Twist Bioscience Corporation reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Twist Bioscience Corporation report Q2 2026 earnings?
Twist Bioscience Corporation (TWST) reported Q2 2026 earnings on May 4, 2026 before market open.
What were Twist Bioscience Corporation's Q2 2026 revenue and EPS?
Twist Bioscience Corporation reported revenue of $110.7M and eps of $-0.62 for Q2 2026.
Did Twist Bioscience Corporation beat estimates in Q2 2026?
Revenue beat the consensus estimate of $107.6M by $3.1M. EPS missed the consensus estimate of $-0.49 by $0.13.
How did Twist Bioscience Corporation's Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 19.3% from $92.8M a year earlier and eps grew 6.1% from $-0.66.
Where can I find Twist Bioscience Corporation's Q2 2026 SEC filings?
You can read the 8-K earnings release (0001581280-26-000037) and the 10-Q periodic report (0001581280-26-000040) directly on SEC EDGAR. The filing index links above go to sec.gov.